Proteocyte Diagnostics hosts successful first global meeting on Straticyte™

Proteocyte Diagnostics hosted their first global Straticyte™ meeting at the 6th World Oral Cancer Congress of the International Academy of Oral Oncology (IAOO) in India  on May 18, 2017.

The meeting included leading oral cancer healthcare professionals from around the world.

Straticyte™ offers a new avenue in predicting the risk of oral cancer.
— Dr. Jatin Shah, Memorial Sloan Kettering Cancer Center, New York

For the full press release, click here

Previous
Previous

CAAP Company: Proteorex Therapeutics announces research and development collaboration with Corbin Therapeutics

Next
Next

CAAP Company: Komodo OpenLab Featured in PANAMERICA Magazine